Polymyxins: To Combine or Not to Combine?
Polymyxins have been a mainstay for the treatment of extensively drug resistant (XDR) Gram-negative bacteria for the past two decades. Many questions regarding the clinical use of polymyxins have been answered, but whether the administration of polymyxins in combination with other antibiotics leads...
Saved in:
Main Authors: | Federico Perez (Author), Nadim G. El Chakhtoura (Author), Mohamad Yasmin (Author), Robert A. Bonomo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study
by: Thien B. Tran, et al.
Published: (2018) -
Polymyxins-Curcumin Combination Antimicrobial Therapy: Safety Implications and Efficacy for Infection Treatment
by: Chongshan Dai, et al.
Published: (2020) -
Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant Pseudomonas aeruginosa
by: Yu-Wei Lin, et al.
Published: (2019) -
Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant <i>Acinetobacter baumannii</i> with Polymyxin-Based Combinations
by: Marisol Wences, et al.
Published: (2022) -
Mechanisms Underlying Synergistic Killing of Polymyxin B in Combination with Cannabidiol against <i>Acinetobacter baumannii</i>: A Metabolomic Study
by: Maytham Hussein, et al.
Published: (2022)